<DOC>
	<DOCNO>NCT02038790</DOCNO>
	<brief_summary>The primary objective study compare overall patient preference either Suboxone® sublingual film 8/2 Zubsolv® sublingual tablet 5.7/1.4 . Suboxone sublingual film 8/2 contain 8mg buprenorphine 2mg naloxone . Zubsolv sublingual tablet contain 5.7 mg buprenorphine 1.4 mg naloxone . Both intervention act substitute opiate drug like heroin , morphine oxycodone help withdrawal opiate drug period time .</brief_summary>
	<brief_title>Usability Zubsolv Sublingual Tablets 5.7/1.4 Suboxone Sublingual Film 8/2 In Buprenorphine/Naloxone Treated Opioid Dependent Population</brief_title>
	<detailed_description />
	<mesh_term>Analgesics , Opioid</mesh_term>
	<mesh_term>Buprenorphine , Naloxone Drug Combination</mesh_term>
	<mesh_term>Buprenorphine</mesh_term>
	<mesh_term>Naloxone</mesh_term>
	<criteria>currently single daily dose 8/2 Suboxone generic equivalent , 5.7/1.4 mg Zubsolv treatment opioid dependence medically confirm . good general health specific contraindication treatment buprenorphine naloxone . ability understand , sign date write consent Health Information Portability Accountability Act ( HIPAA ) authorization form , must obtain prior study related procedure complete . Female subject must postmenopausal least 2 year , surgically sterile ( i.e . tubal ligation , hysterectomy , bilateral ovariectomy ) , practice effective method contraception study one follow method : oral contraception , intrauterine device ( IUD ) , abstinence , contraceptive injection , conscientious use diaphragm condom spermicidal foam , systemic ( implant ) contraception partner vasectomy . Subject take opioids ( buprenorphine/naloxone ) may interfere study evaluation compromise safety subject . Subject able read impairment may prevent completion questionnaire study evaluation Subject open sore present oral cavity . Subject participate previous clinical test involve investigational drug within 4 week prior study start . Subject pregnant , lactate plan pregnancy Subject currently participate type clinical testing . Subject medical condition Investigator 's opinion could affect taste assessment require study Subject judge Investigator review medical history unsuitable reason may either place subject increase risk participation interfere interpretation study outcome .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>opioid dependence</keyword>
	<keyword>buprenorphine/naloxone</keyword>
	<keyword>Opioid-Related Disorders</keyword>
</DOC>